STREAMEX CORP. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- STREAMEX CORP. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $1.72M, a 55.59% decline year-over-year.
- STREAMEX CORP. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $16.45M.
- STREAMEX CORP. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $0.00.
- STREAMEX CORP. stock issued during period, value, new issues for the quarter ending 2025-06-30 was -$2.87M.
- STREAMEX CORP. stock issued during period, value, new issues for fiscal 2025 was $17.45M.
- STREAMEX CORP. stock issued during period, value, new issues for fiscal 2023 was $60.00K, a 97.10% decline from fiscal 2022.
- STREAMEX CORP. stock issued during period, value, new issues for fiscal 2022 was $2.07M.
- STREAMEX CORP. stock issued during period, value, new issues for fiscal 2020 was $25.21M, a 151.97% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $1.72M 10-Q · filed 2026-05-14 | $15.30M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | $16.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $17.45M 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | |
| 2025-06-30 | -$2.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | |
| 2025-03-31 | $3.88M 10-Q · filed 2026-08-14 | |
| 2023-12-31 | $60.00K 10-K · filed 2025-04-15 | |
| 2023-09-30 | -$3.00K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $2.07M 10-K · filed 2024-04-16 | |
| 2022-09-30 | $807.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $302.00K 10-Q · filed 2023-11-14 | |
| 2021-09-30 | $9.01M 10-Q · filed 2021-11-15 | |
| 2020-12-31 | $689.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $25.21M 10-K · filed 2022-03-31 |
| 2020-09-30 | $1.00M 10-Q · filed 2021-11-15 | $27.60M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $16.16M 10-Q · filed 2021-11-15 | $26.60M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-03-31 | $9.05M 10-Q · filed 2021-11-15 | $10.44M derived: sum of 4 quarters · filed 2021-11-15 |
| 2019-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $10.01M 10-K · filed 2021-03-15 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $8.62M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $12.49M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $8.62M 10-Q · filed 2020-05-11 | $17.37M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $9.14M 10-K · filed 2020-03-13 |
| 2018-09-30 | $3.87M 10-Q · filed 2019-10-23 | $10.91M derived: sum of 4 quarters · filed 2019-10-23 |
| 2018-06-30 | $4.88M 10-Q · filed 2019-07-31 | $8.12M derived: sum of 4 quarters · filed 2019-07-31 |
| 2018-03-31 | $270.00K 10-Q · filed 2019-04-15 | $4.48M derived: sum of 4 quarters · filed 2019-04-15 |
| 2017-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $6.01M 10-K · filed 2019-03-15 |
| 2017-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $6.29M derived: sum of 4 quarters · filed 2018-02-27 |
| 2017-06-30 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $5.74M derived: sum of 4 quarters · filed 2018-02-27 |
| 2017-03-31 | $1.80M 10-Q · filed 2017-05-09 | $6.67M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $5.23M 10-K · filed 2018-02-27 |
| 2016-09-30 | $530.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $4.77M derived: sum of 4 quarters · filed 2017-04-11 |
| 2016-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $4.24M derived: sum of 4 quarters · filed 2017-04-11 |
| 2016-03-31 | $352.00K 10-Q · filed 2016-05-04 | $2.07M derived: sum of 4 quarters · filed 2017-04-11 |
| 2015-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-11 | $4.76M 10-K · filed 2017-04-11 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $3.47M derived: sum of 4 quarters · filed 2016-03-14 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-28 | $4.28M derived: sum of 4 quarters · filed 2016-03-14 |
| 2015-03-31 | $3.04M 10-Q · filed 2015-05-01 | |
| 2014-12-31 | $432.12K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $1.97M 10-K · filed 2016-03-14 |
| 2014-09-30 | $804.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-17 | |
| 2013-12-31 | $247.17K 10-K · filed 2015-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |